Artesunate inhibits the development of esophageal cancer by targeting hk1 to reduce glycolysis levels in areas with zinc deficiency

HIGHLIGHTS

• who: Jing Jin from the Cancer Institute, Fourth Hospital of Hebei Medical University, Shijiazhuang, China have published the research: Artesunate Inhibits the Development of Esophageal Cancer by Targeting HK1 to Reduce Glycolysis Levels in Areas With Zinc Deficiency, in the Journal: (JOURNAL)
• what: This study explores the role and mechanism of artesunate in EC.
• how: The results showed that the cell activity was significantly inhibited in both KYSE150 and KYSE170 cells at a dose of 10 mmol/L which might indicate cytotoxicity . The results showed that artesunate mainly affects 20 metabolic pathways through . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.